us.astellas.comAstellas Pharma US | Changing Tomorrow | Home

Sorry, you need to enable JavaScript to visit this website. Skip to main content Search Search US About U.S. Products Medical Safety Safety Data Sheets (v 3.0) Philosophy Charter of Corporate Conduct U.S. Corporate Profile Locations Group Code of Conduct Leadership Percival Barretto-Ko Joe Devaney Shontelle Dodson Lynn Fenicchia Moyra Knight Mark Reisenauer Steve Sabus Regulations State Regulations California Declaration of Comprehensive Compliance Program Vermont’s Pharmaceutical Marketer Price Disclosure Wholesale Acquisition Cost Information for Colorado Prescribers Consumer Product Safety Commission Regulations Company Facts Astellas Fact Sheet Corporate Brochure Annual Report 2019 Policies & Position Statements Contact Us Procurement Procurement News Prospective Suppliers Existing Suppliers Contact & Resources Authorized Distributors of Records PO terms and conditions Vision & Strategy Governance History Political Contributions Recommended U.S. Corporate Profile Learn more about Astellas U.S. Read More Innovation Partnering Track Record Areas of Interest Partnering Inquiry R&D Approach Clinical Trials Ethics & Principles Pipeline Recommended Clinical Trials This website provides access to information from Astellas sponsored clinical trials and the purpose is not to promote or advertise any... Read More Corporate Responsibility COVID-19 Community Response Commitment To Transparency U.S. Sunshine Act Overview Changing Tomorrow Day Annual Report 2019 Corporate Grants Access Accelerated Employee Impact Patient Advocacy Awards & Recognition Recommended Annual Report 2019 Steady results as projected for the first year of Strategic Plan 2018. Read More News News Releases Stories Corporate Corporate Awards Corporate Social Responsibility Our People Therapeutic Area News The Astellas Way Blog Feature Stories Video Gallery Statements Media Inquiries Recommended Feature Stories Feature Stories showcase the people and programs that bring to life the Astellas Way values and culture. Read More Stakeholders menu COVID-19 Response Patients & Caregivers Support for Patients Astellas Pharma Support Solutions Issues that Matter to You Careers Partnering Common header menu IMPORTANT NOTICE WORLDWIDE US WORLDWIDE - US Important Notice This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider. I Agree You are now leaving www.astellas.com/us. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site. Cancel Click here to leave this site. Previous Pause Next ASTELLAS IS COMMITTED TO COMMUNITY SUPPORT We are dedicated to supporting local and global communities as part of our COVID-19 response Read More Astellas ranks in Top 10 of Working Mother Magazine’s Best Companies List We are committed to creating a diverse and inclusive workplace that enables success for all employees Read More WE CAN CHANGE CANCER CARE Astellas Oncology opens annual C3 Prize call for entries to award best innovations in cancer care beyond medicine Read More UPDATES AND INFORMATION Find out how we're responding to our patients, our employees and our community Read More 1 2 3 4 News Latest News / Media Jul 22, 2020 Astellas is Awarded Grant from the U.S. National Institutes of Health (NIH) to Fund Early Clinical Studies of ASP8062 to Investigate Potential Novel Therapeutic Approach to Address the Opioid Crisis Read More News / Media Jul 20, 2020 Astellas Named to FTSE4Good Index Series for Ninth Consecutive Year Read More News / Media Jun 05, 2020 Astellas, City of Yokohama, and Yokohama City University Developed Science-Based Exercise Programs through Industry-Government-Academia Collaboration Read More News / CSR Oct 01, 2020 Astellas Celebrates First-Ever Virtual Day of Service to Help Non-Profit Organizations Respond to Local Community Needs Read More News / Corporate Sep 29, 2020 Astellas and MBC BioLabs Announce Golden Ticket Competition to Help Biotech Start-ups Accelerate Early Drug Discovery and Research Efforts Read More News / Therapeutic Area News Sep 28, 2020 Astellas' Real-World Evidence Studies Provide Further Insight into Negative Impacts of Vasomotor Symptoms (VMS) Associated with Menopause Read More View All >> Patients & Caregivers Learn more about resources designed to meet the needs of patients and caregivers Read More Investors Access financial information, investor relations library, analyst coverage and more Read More Contact Us Call us at (800) 888-7704, M-F, 8AM-7PM CT Read More Homepage External Link Follow us on social media Bottom footer menu SITE MAP PRIVACY POLICY ACCESSIBILITY LEGAL DISCLAIMER CONTACT US © 2020 Astellas Pharma US, Inc....